A one-time-only drug to treat spinal muscular atrophy (SMA) that will cost NT$49 million (US$1.58 million) will soon be covered for infants six months old and under by Taiwan's universal health insurance system.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Lai's WWII remarks warn of China's bid to reshape world order: Analysts
10/10/2026 07:27 PM - Business
Gasoline, diesel prices to remain unchanged next week: CPC
10/10/2026 06:09 PM - Politics
Opposition leaders criticize DPP, Lai in National Day remarks
10/10/2026 04:48 PM - Politics
Ex-President Tsai calls for deeper ties between Taiwan, Silicon Valley
10/10/2026 04:25 PM - Society
Filipino worker hospitalized, over 300 evacuated in Tainan dorm fire
10/10/2026 03:59 PM